To retrospectively evaluate the value of contrast‐enhanced ultrasound (CEUS) perfusion parameters in the differential diagnosis of hepatocellular carcinomas (HCCs) and metastatic liver tumors (MLTs) with hypervascularity. Click to show full abstract
To retrospectively evaluate the value of contrast‐enhanced ultrasound (CEUS) perfusion parameters in the differential diagnosis of hepatocellular carcinomas (HCCs) and metastatic liver tumors (MLTs) with hypervascularity.
               
Click one of the above tabs to view related content.